Navigation Links
Live Xtalks Webinar Highlights Vaccine and Biotherapeutic Formulation Development and Manufacture Using Spray-Drying
Date:6/24/2013

Toronto, Canada (PRWEB) June 24, 2013

The pharmaceutical industry has increasingly focused on the formulation of vaccines and biotherapeutics, especially by spray-drying. Spray-drying is being pursued as a promising alternative to lyophilization for vaccines and biotherapeutic formulations due to the inherent robustness and efficiency of the technology, as well as the ability to produce particles with desirable and reproducible properties. Solid-state stabilization for ambient compound storage, high-concentration protein processing, and parenteral or inhalation delivery have attracted specific interest.

This webinar will discuss current approaches in the design, testing, and manufacture of spray-dried powder formulations. Leading experts from Bend Research Inc. will discuss case studies that highlight new breakthroughs in this area.

Formulation design and spray-drying process parameters will be discussed, focusing on product specifications. The utility of solid-state characterization tools such as differential scanning calorimetry, vapor sorption, and x-ray diffraction will be presented.

To learn more about the event, visit: http://xtalks.com/Vaccine-Biotherapeutic-Formulation.ashx.

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks, visit http://xtalks.com/ContactUs.ashx.

Contact:
Karen Lim (416) 977-6555 ext 227
clientservices(at)xtalks(dot)com

Read the full story at http://www.prweb.com/releases/2013/6/prweb10852102.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Study Data Tabulation Model in Real Time, New Webinar Hosted by Xtalks
2. Cross-Cultural Qualitative Research for Simultaneous Scale Development, New Life Science Webinar Hosted by Xtalks
3. Navigating the Dynamic Indian Clinical Trial Landscape, New Webinar Hosted by Xtalks
4. Drug Advertising and Promotion Labeling: FDA Regulations, New Webinar Hosted by Xtalks
5. Quantitative Analysis of Biomarkers, New Life Science Webinar Hosted by Xtalks
6. Practical Uses for Flow Cytometry in Toxicology Studies Within a Glp Environment, New Life Science Webinar Hosted by Xtalks
7. Optimize Your Product Launch in a Multi-stakeholder Environment, New Webinar Hosted by Xtalks
8. New Advances and Opportunities in Managing Pain: Translational Animal Models, New Webinar Hosted by Xtalks
9. Driving Predictability in Clinical Development through Innovation, An Interactive Webinar Hosted by Xtalks
10. Clinical Development, Contracts and Outsourcing in MENA & APAC, New Webinar Hosted by Xtalks
11. Drug Safety & Risk Management, New Webinar Hosted by Xtalks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 23, 2016  Blueprint Bio, a company dedicated to ... medical community, has closed its Series A funding round, ... "We have received a commitment from Forentis ... need to meet our current goals," stated Matthew ... runway to complete validation on the current projects in ...
(Date:6/23/2016)... -- On Wednesday, June 22, 2016, the NASDAQ ... Dow Jones Industrial Average edged 0.27% lower to finish at ... Stock-Callers.com has initiated coverage on the following equities: Infinity Pharmaceuticals ... NKTR ), Aralez Pharmaceuticals Inc. (NASDAQ: ARLZ ... Learn more about these stocks by accessing their free trade ...
(Date:6/23/2016)... ... 23, 2016 , ... Regulatory Compliance Associates® Inc. (RCA), a ... webinar on Performing Quality Investigations: Getting to Root Cause. This ... charge. , Incomplete investigations are still a major concern to the Regulatory Authorities ...
(Date:6/23/2016)... June 22, 2016  Amgen (NASDAQ: AMGN ... QB3@953 life sciences incubator to accelerate the ... shared laboratory space at QB3@953 was created to help ... obstacle for many early stage organizations - access to ... sponsorship, Amgen launched two "Amgen Golden Ticket" awards, providing ...
Breaking Biology Technology:
(Date:4/28/2016)... April 28, 2016 First quarter 2016:   ... 966% compared with the first quarter of 2015 The ... 589.1 M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) ... guidance is unchanged, SEK 7,000-8,500 M. The operating margin ...
(Date:4/15/2016)... , April 15, 2016 ... the,  "Global Gait Biometrics Market 2016-2020,"  report to ... http://photos.prnewswire.com/prnh/20160330/349511LOGO ) , ,The global gait biometrics ... of 13.98% during the period 2016-2020. ... angles, which can be used to compute factors ...
(Date:3/29/2016)... March 29, 2016 LegacyXChange, Inc. ... "LEGX" and SelectaDNA/CSI Protect are pleased to announce our ... in a variety of writing instruments, ensuring athletes signatures ... created collectibles from athletes on LegacyXChange will be assured ... the DNA. Bill Bollander , CEO ...
Breaking Biology News(10 mins):